[HTML][HTML] Frontocingulate dysfunction in depression: toward biomarkers of treatment response

DA Pizzagalli - Neuropsychopharmacology, 2011 - nature.com
Increased rostral anterior cingulate cortex (rACC) activity has emerged as a promising
predictor of treatment response in depression, but neither the reliability of this relationship …

A systematic meta-review of predictors of antidepressant treatment outcome in major depressive disorder

K Perlman, D Benrimoh, S Israel, C Rollins… - Journal of affective …, 2019 - Elsevier
Introduction The heterogeneity of symptoms and complex etiology of depression pose a
significant challenge to the personalization of treatment. Meanwhile, the current application …

Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy

S Porcelli, C Fabbri, A Serretti - European Neuropsychopharmacology, 2012 - Elsevier
In the last decade the serotonin transporter gene promoter polymorphism (5-HTTLPR) was
likely the most studied genetic variant as predictor of antidepressant response. Nevertheless …

Antidepressant efficacy of the antimuscarinic drug scopolamine: a randomized, placebo-controlled clinical trial

ML Furey, WC Drevets - Archives of general psychiatry, 2006 - jamanetwork.com
Context The need for improved therapeutic agents that more quickly and effectively treat
depression is critical. In a pilot study we evaluated the role of the cholinergic system in …

Socio-demographic and clinical predictors of non-response/non-remission in treatment resistant depressed patients: a systematic review

V De Carlo, R Calati, A Serretti - Psychiatry research, 2016 - Elsevier
Up to one third of patients adequately treated for Major Depressive Disorder (MDD) do not
respond to multiple interventions. Many studies investigated predictors in MDD outcome, but …

Replication of scopolamine's antidepressant efficacy in major depressive disorder: a randomized, placebo-controlled clinical trial

WC Drevets, ML Furey - Biological psychiatry, 2010 - Elsevier
BACKGROUND: We previously reported that intravenous (IV) scopolamine administration
produced rapid and robust antidepressant effects in a sample consisting of both unipolar …

Duration of untreated depression influences clinical outcomes and disability

L Ghio, S Gotelli, A Cervetti, M Respino, W Natta… - Journal of affective …, 2015 - Elsevier
Background The duration of untreated depression (DUD) might have a substantial impact on
the clinical outcomes; however, there are important knowledge gaps including the effects on …

Neurophysiological predictors of non-response to rTMS in depression

M Arns, WH Drinkenburg, PB Fitzgerald, JL Kenemans - Brain stimulation, 2012 - Elsevier
BACKGROUND: The application of rTMS in Depression has been very well investigated
over the last few years. However, little is known about predictors of non-response associated …

Investigating the nature of co-occurring depression and anxiety: Comparing diagnostic and dimensional research approaches

K Kircanski, J LeMoult, S Ordaz, IH Gotlib - Journal of affective disorders, 2017 - Elsevier
Background Although approximately half of adults diagnosed with a depressive or anxiety
disorder exhibit their simultaneous co-occurrence, traditional research has centered on …

Melancholia: the diagnosis, pathophysiology and treatment of depressive illness

MA Taylor, M Fink - 2006 - books.google.com
This book provides a comprehensive review of melancholia as a severe disorder of mood,
associated with suicide, psychosis, and catatonia. The syndrome is defined with a clear …